Amgen
–
Washington, DC, 20001
... Dev TA heads, GDL/EDL, GSL, Pre-clinical biomaker and CBD biomarker and CDx leads) regarding biomarker exploratory analysis for evidence generation and product strategy Sets and drives strategic application of exploratory analysis of RUO (Research ... - Apr 06